Table 1.
Demographics
| Variable | OPCAB + HA (n = 10) |
|---|---|
| Age, years | 67.4 ± 9.2 |
| Gender, male | 8 (80) |
| Prior PCI | 5 (50) |
| Emergency indication (< 24 h) | 1 (10) |
| Urgent indication | 9 (90) |
| Acetylsalicylic acid | 10 (100) |
| Ticagrelor | 8 (80) |
| Rivaroxaban | 1 (10) |
| Ticagrelor + rivaroxaban | 1 (10) |
| NYHA functional class III/IV | 10 (100) |
| Hypertension | 9 (90) |
| Diabetes (NIDDM/IDDM) | 4/1 (34.2) |
| Hyperlipidaemia | 10 (100) |
| History of smoking | 6 (60) |
| Renal dysfunction (creatinine ≥ 1.3 mg/dL / failure (dialysis) | 2 (80) |
| Ejection fraction normal | 8 (20) |
| Ejection fraction moderate impaired (40%; 45%) | 2 (20) |
| BMI | 28,8 ± 4,3 |
| BMI > 30 | 3 (30) |
| EuroSCORE II, % | 2.9 ± 1.5 |
Data are presented as number (%) or mean±SD; h, hours; OPCAB, off-pump coronary artery bypass grafting; HA, hemoadsorption; NYHA, New York Heart Association; EuroSCORE, European System for Cardiac Operative Risk Evaluation; NIDDM, non-insulin dependent diabetes mellitus; IDDM, insulin dependent diabetes mellitus; PCI, percutaneous coronary intervention; BMI, body mass index